Imagion Biosystems

Imagion Biosystems Net Margin

The Net Profit Margin of Imagion Biosystems (IBX.AX) as of Oct 17, 2026 is -13,313.12 %. In the previous year, Net Profit Margin was -77.56 % — a change of 17,065.94% (lower).

Net Margin

-13,313.12 %

YoY

17,065.94%

Last updated:

Net Profit Margin of Imagion Biosystems is 2025 -13,313.12 % . Net Profit Margin of Imagion Biosystems was 2024 -77.56 % . It decreases by 17,065.94% lower compared to the previous year.

For Imagion Biosystems, the net margin of -13,313.1% is down versus -2,587.2% a few years ago.

The Imagion Biosystems Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-4,359.67 AUD
Jan 1, 2019
-835.46 AUD
Jan 1, 2020
-2,607.47 AUD
Jan 1, 2021
-2,587.21 AUD
Jan 1, 2022
-2,071.95 AUD
Jan 1, 2023
-1,151.86 AUD
Jan 1, 2024
-77.56 AUD
Jan 1, 2025
-13,313.12 AUD
The Imagion Biosystems Net Margin history
YEARNet MarginYoY
-13,313.12 %+17,065.94%
-77.56 %-93.27%
-1,151.86 %-44.41%
-2,071.95 %-19.92%
-2,587.21 %-0.78%
-2,607.47 %+212.10%
-835.46 %-80.84%
-4,359.67 %-88.76%
-38,775.26 %-99.55%
-8.62 M %+10,658.99%
-80,124.99 %+94.67%
-41,159.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Imagion Biosystems Stock analysis

What does Imagion Biosystems do? Imagion Biosystems Ltd is a Melbourne-based company operating in the Health Care sector. It focuses on research and development of non-radioactive diagnostic imaging technology. The company went public on June 22, 2017. Its MagSense technology uses bio-safe magnetic nanoparticles for cancer detection, specifically formulated for breast, prostate, and ovarian cancers. MagSense nanoparticles are injectable solutions tailored to each cancer type. The firm also develops PrecisionMRX nanoparticles for magnetic relaxometry, available in various coatings including dextran, mPEG, oleic acid, and carboxylic acid functionalized. Imagion Biosystems operates through a Research and Development segment. Imagion Biosystems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imagion Biosystems stock

Net Profit Margin of Imagion Biosystems is -13,313.12 % in 2025.

Net Profit Margin of Imagion Biosystems changed from -77.56 % to -13,313.12 %, representing a 17,065.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Imagion Biosystems since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Imagion Biosystems with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Imagion Biosystems

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Imagion Biosystems